BiVACOR

bivacor.com

Bi VACOR, Inc. is a clinical-stage medical device company focused on developing the Total Artificial Heart (TAH) to address the global unmet need for patients with severe heart failure. The TAH is designed to replace the complete function of the native heart, providing a life-extending solution for patients awaiting transplants. With a unique electro-mechanical rotary blood pump design, the Bi VACOR TAH offers high flow rates, durability, and portability, setting it apart from traditional heart technologies. The company is currently conducting an FDA-approved Early Feasibility Study, having successfully implanted the device in patients, showcasing its innovative approach and commitment to advancing cardiac care.